Abstract
Following the sudden death of her four infant children, Kathleen Folbigg was sentenced to 40 years in prison largely on the basis of sir Roy Meadow’s axiom. The discovery of the CALM2-G114R variant in the mother and in her two dead daughters prompted a series of laboratory studies which, together with the critical information on the genotype–phenotype correlation of patients with calmodulinopathies provided by the International Calmodulinopathy Registry, led to a reversal of the initial sentence and to her release after 20 years in prison.
Original language | English |
---|---|
Journal | European Heart Journal |
ISSN | 0195-668X |
DOIs | |
Publication status | E-pub ahead of print - 9 Apr 2024 |
Fingerprint
Dive into the research topics of 'Calmodulin, sudden death, and the Folbigg case: genes in court'. Together they form a unique fingerprint.Impacts
-
Research into genetic defect can pardon Australian woman
Helene Halkjær Jensen (Participant), Malene Bredal Brohus (Participant), Michael Toft Overgaard (Participant) & Mette Nyegaard (Participant)
Impact: Social impact